FIELD: chemistry.
SUBSTANCE: invention refers to medicine, and may be used for changing the functional status of an individual. The individual's open eyes are exposed to white light at colour temperature 1700 °K or 10000 °K, at lighting intensity 200 lx at the eye level. That is followed by electroencephalogram recording and spectral analysis. If an alpha wave spectral power increases by more than 50%, while a teta wave spectral power increases by more than 25% of a baseline value, the effect is considered to be relaxant.
EFFECT: method enables assessing the action of colour temperature individually that can cause the relaxant effect on an individual.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSESSING LIGHT EXPOSURE ON FUNCTIONAL STATUS OF HUMAN BRAIN | 2012 |
|
RU2515150C2 |
METHOD FOR ACTIVATING EFFECT OF OPTICAL EMISSION GENERATED BY LIGHT-EMITTING-DIODE SOURCE ON HUMAN FUNCTIONAL STATUS | 2012 |
|
RU2517367C2 |
DIAGNOSTIC TECHNIQUE OF COGNITIVE DISORDERS IN THE PATIENTS WITH HEMISPHERIC ISCHEMIC STROKE IN THE ACUTE PERIOD | 2019 |
|
RU2712037C1 |
METHOD OF ESTIMATING EFFICIENCY OF PERFORMED THERAPY OF COGNITIVE DISORDERS AT REHABILITATION STAGE IN PATIENTS WITH VIBRATION DISEASE | 2011 |
|
RU2457779C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF BEHAVIORAL REACTIONS | 2017 |
|
RU2663642C1 |
METHOD FOR DIAGNOSING A PATHOLOGICAL DESIRE FOR ALCOHOL | 2017 |
|
RU2670910C9 |
METHOD OF DIAGNOSING DYSFUNCTION OF FRONTAL LOBES IN PATIENTS WITH VIBRATION DISEASE | 2011 |
|
RU2457780C1 |
METHOD FOR DIAGNOSING AUTISM SPECTRUM DISORDERS IN CHILDREN | 2022 |
|
RU2787463C1 |
METHOD OF DETERMINATION OF INDICATIONS FOR TREATMENT OF AMBLIOPY USING THE NEUROPEPTIDE PREPARATION | 2017 |
|
RU2647324C1 |
METHOD FOR PREDICTING DIFFERENT STAGES OF EPILEPTOGENESIS | 2004 |
|
RU2297791C2 |
Authors
Dates
2014-05-10—Published
2012-07-27—Filed